Monitoring of Implant Diseases: Diagnosis and Monitoring with AMMP-8 Test Technology
IMP_TRE
1 other identifier
interventional
50
1 country
1
Brief Summary
68 patients underwent the aMMP-8 chair-side test as well as clinical traditional measurement methods. Those who had one or more implants in their mouth were selected as patients. The condition of the attachment tissues of these implants is monitored at a control visit after five years.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jan 2025
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 25, 2024
CompletedFirst Posted
Study publicly available on registry
January 7, 2025
CompletedStudy Start
First participant enrolled
January 11, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 11, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
November 20, 2025
CompletedMarch 6, 2025
March 1, 2025
8 months
September 25, 2024
March 5, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Tratitional measurement
the depth of the implant's gum pocket
5 years
Traditional measure
Bleedin on probing
through study completion, an average of 5 year
Biomarker test
aMMP-8 tests, taking peri-implant sulcus fluid
through study completion, an average of 5 year
Study Arms (1)
patients who had participated in a previous study
OTHERBleeding on probing, Peri-implant pocket depth, x-ray findings and aMMP-8 tests will be taking.
Interventions
peri-implant mucositis, peri-implantitis
Eligibility Criteria
You may qualify if:
- the participation previously study implant patient
You may not qualify if:
- has not received antibiotic treatment within 6 months
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Hanna Lahteenmakilead
- University of Helsinkicollaborator
Study Sites (1)
Department of Oral and Maxillofacial Diseases, Head and Neck Center
Helsinki, Uusimaa, FI-00014, Finland
Related Publications (4)
Lahteenmaki H, Umeizudike KA, Heikkinen AM, Raisanen IT, Rathnayake N, Johannsen G, Tervahartiala T, Nwhator SO, Sorsa T. aMMP-8 Point-of-Care/Chairside Oral Fluid Technology as a Rapid, Non-Invasive Tool for Periodontitis and Peri-Implantitis Screening in a Medical Care Setting. Diagnostics (Basel). 2020 Aug 5;10(8):562. doi: 10.3390/diagnostics10080562.
PMID: 32764436BACKGROUNDNatto ZS, Almeganni N, Alnakeeb E, Bukhari Z, Jan R, Iacono VJ. Peri-Implantitis and Peri-Implant Mucositis Case Definitions in Dental Research: A Systematic Assessment. J Oral Implantol. 2019 Apr;45(2):127-131. doi: 10.1563/aaid-joi-D-18-00097. Epub 2018 Dec 17.
PMID: 30557088BACKGROUNDSorsa T, Tervahartiala T, Leppilahti J, Hernandez M, Gamonal J, Tuomainen AM, Lauhio A, Pussinen PJ, Mantyla P. Collagenase-2 (MMP-8) as a point-of-care biomarker in periodontitis and cardiovascular diseases. Therapeutic response to non-antimicrobial properties of tetracyclines. Pharmacol Res. 2011 Feb;63(2):108-13. doi: 10.1016/j.phrs.2010.10.005. Epub 2010 Oct 16.
PMID: 20937384BACKGROUNDTonetti MS, Greenwell H, Kornman KS. Staging and grading of periodontitis: Framework and proposal of a new classification and case definition. J Periodontol. 2018 Jun;89 Suppl 1:S159-S172. doi: 10.1002/JPER.18-0006.
PMID: 29926952BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Timo Sorsa, Professor
University of Helsinki
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SCREENING
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Doctor, Dental hygienist
Study Record Dates
First Submitted
September 25, 2024
First Posted
January 7, 2025
Study Start
January 11, 2025
Primary Completion
September 11, 2025
Study Completion
November 20, 2025
Last Updated
March 6, 2025
Record last verified: 2025-03
Data Sharing
- IPD Sharing
- Will not share